Search

The article discusses the paper "Cathepsin K-dependent Toll-like receptor 9 signaling revealed in experimental arthritis," by M. Asagiri and colleagues. The study demonstrates the role of NC-2300, an orally active cathepsin K inhibitor, in bone resorption by osteoclasts and in mediating immune responses. The data describe a new role for cathepsin K in Toll-like receptor 9 (TLR9) signaling in response to unmethylated CpG-containing DNA and in the production of interleukin-6 (IL-6) and IL-23.

The article discusses recent research in the field of antiviral immunity based on the original research paper "IL-21 is required to control chronic viral infection," by H. Elsaesser. K. Sauer, and D.G. Brooks that was published in the May 7, 2009 issue of "Science." The article mentions T cells, viral infections, and lymphocytic choriomeningitis virus (LCMV).

The article discusses two studies published in "Nature Medicine" which describe new roles for interleukin-22 (IL-22), an IL-10-family cytokine that is mainly produced by T helper 17 (TH17) cells, in host defense at mucosal surfaces. It highlights the key findings of the papers "Interleukin-22 mediates mucosal host defense against Gram-negative bacterial pneumonia" and "Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens."

Presents an update on papers related to immunology as of January 2003. Impact of cytokines on surface lymphotoxinαβ; Immunoregulatory cells that can mediate graft rejection; Role of interleukin-21 receptor in regulating immunoglobulin production.